Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- RPM +1.0%
Other news:
- CYOU +10% (declares special cash dividend of $9.40/ADS)
- ATRS +5.7% (announces that the FDA acknowledged receipt of the resubmission to the Complete Response Letter received in connection with the XYOSTED New Drug Application)
- SGMO +3.7% (after closing up 6% on the day)
- FB +3.6% (Facebook CEO Zuckerberg hosts call with media)
- PRTK +3% (Paratek's new drug applications for oral and intravenous omadacycline accepted for priority review by FDA)
- ICPT +1.8% (proposes $120 million offering and concurrent $92 million private placement of common stock; CEO and Board members indicated interest in participating in the offering; expects net sales of Ocaliva for the quarter ended March 31, 2018 will be slightly lower y/y)
- CASI +1.6% (after Exec Chairman Wei-Wu He and founder of Emerging Technology Partners affirmed increased active stake of 10.4% following previously disclosed securities purchase agreement)
- SAND +1.3% (Sandstorm Gold sold ~14,650 attributable gold equivalent ounces during Q1)
- ZS +0.9% (after seeing late move higher on reports that Cisco previously made bid for company), .
Analyst comments:
- FNSR +5.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- MRVL +4.3% (initiated with Buy rating at UBS)
- CDNS +3.1% (upgraded to Buy from Neutral at DA Davidson)
- AMD +3.1% (upgraded to Buy from Hold at Stifel)
- AXP +1.8% (initiated with a Buy at Citigroup)
- TTD +1.5% (initiated with a Overweight at Piper Jaffray)
- LRCX +1.4% (initiated with a Neutral at UBS)
- MRK +1.2% (upgraded to Overweight from Equal Weight at Barclays)
- AVGO +1.1% (initiated with Buy rating at UBS)
- AZO +1% (upgraded to Outperform from Neutral at Wedbush)
- TIF +0.5% (upgraded to Buy from Hold at Loop Capital)